Halozyme Therapeutics | HALO - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amarin USD 308M 18M 2026-03
Amgen USD 176.25B 24.32B 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Cara Therapeutics USD 28M 11M 2024-12
Cytokinetics USD 7.77B 1.19B 2025-12
DBV Technologies USD 745M 471M 2026-03
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 475M 410M 2026-03
Halozyme Therapeutics USD 7.91B 664M 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
MannKind USD 1.74B 93M 2025-12
Pfizer USD 153.96B 12.4B 2026-03
United Therapeutics USD 20.98B 2.02B 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12